Omari Mohammed, Maiouak Moncef, Bahra Nassiba, El Harch Ibtissam, Youbi Mohammed, Belakhel Latifa, Abousselham Loubna, Otmani Nada, Mohammed Faouzi Belahcen, Tachfouti Nabil
Laboratory of Epidemiology, Clinical Research and Community Health, Faculty of Medicine and Pharmacy, Sidi Mohamed Ben Abdellah University, Fez, MAR.
Department of Epidemiology and Disease Control, Ministry of Health and Social Protection, Rabat, MAR.
Cureus. 2023 Jul 20;15(7):e42180. doi: 10.7759/cureus.42180. eCollection 2023 Jul.
Strokes are a group of heterogeneous conditions that can cause lasting brain damage, long-term disability, or even death. In Morocco, the management of this disease generates important expenses and increases the financial burden on health care. In order to rationalize the expenses and to direct the budgetary policy in healthcare, we aimed to estimate the cost of ischemic stroke (IS) management in Morocco through this study.
A cost-of-illness study was conducted between March 2018 and March 2019 at the neurology department of the Hassan II University Hospital, Fez. We included all patients who were admitted, during this period, to the department for IS. The collected data included sociodemographic information, and all details regarding the patient's medical management (diagnosis, treatment, etc.). The cost was estimated using a "bottom-up micro-costing" approach with a societal perspective.
A total of 267 individuals were included in this study with a female predominance (56.6%); the mean age was 66.93 ± 14.83 years. The total cost of ischemic stroke management per patient per year was estimated at $3674.32 ± 1340.81, with a high share related to hospitalization at $1415.06 ± 1015.53. A statistically significant association was found between total cost and age (p=0.014), National Institutes of Health Stroke Scale (NIHSS) score (p≤0.001), and length of hospitalization (p≤0.001); however, no association was found with other factors (sex, complication, Rankin score, etc.).
Ischemic strokes are relatively frequent in Morocco. Their management generates an important cost, which is influenced by several factors such as severity of the disease and the duration of hospitalization. This cost can be decreased by rationalizing the expenses and acting on various risk factors of ischemic strokes.
中风是一组异质性疾病，可导致永久性脑损伤、长期残疾甚至死亡。在摩洛哥，这种疾病的治疗产生了巨额费用，增加了医疗保健的财政负担。为了使费用合理化并指导医疗保健预算政策，我们旨在通过本研究估算摩洛哥缺血性中风（IS）的治疗成本。
2018年3月至2019年3月在非斯哈桑二世大学医院神经科进行了一项疾病成本研究。我们纳入了在此期间因缺血性中风入住该科室的所有患者。收集的数据包括社会人口统计学信息以及患者医疗管理的所有细节（诊断、治疗等）。成本采用“自下而上的微观成本核算”方法从社会角度进行估算。
本研究共纳入267例个体，女性占多数（56.6%）；平均年龄为66.93±14.83岁。缺血性中风患者每年的治疗总成本估计为3674.32美元±1340.81美元，其中很大一部分与住院费用有关，为1415.06美元±1015.53美元。发现总成本与年龄（p=0.014）、美国国立卫生研究院卒中量表（NIHSS）评分（p≤0.001）和住院时间（p≤0.001）之间存在统计学显著关联；然而，未发现与其他因素（性别、并发症、Rankin评分等）存在关联。
缺血性中风在摩洛哥相对常见。其治疗产生了巨额成本，这受到多种因素的影响，如疾病严重程度和住院时间。通过使费用合理化并针对缺血性中风的各种风险因素采取措施，可以降低这一成本。
